ImmunoPrecise Antibodies Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025
IPA Stock | USD 0.41 0.02 5.13% |
About 55% of Immunoprecise Antibodies' investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Immunoprecise Antibodies suggests that some traders are interested. The current market sentiment, together with Immunoprecise Antibodies' historical and current headlines, can help investors time the market. In addition, many technical investors use Immunoprecise Antibodies stock news signals to limit their universe of possible portfolio assets.
Immunoprecise |
IMMUNOPRECISE ANTIBODIES LTD. , an artificial intelligence-driven biotherapeutic research and technology company
Read at businesswire.com
![]() |
Immunoprecise Antibodies Fundamental Analysis
We analyze Immunoprecise Antibodies' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Immunoprecise Antibodies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Immunoprecise Antibodies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Immunoprecise Antibodies is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Immunoprecise Antibodies Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Immunoprecise Antibodies stock to make a market-neutral strategy. Peer analysis of Immunoprecise Antibodies could also be used in its relative valuation, which is a method of valuing Immunoprecise Antibodies by comparing valuation metrics with similar companies.
Peers
Immunoprecise Antibodies Related Equities
STTK | Shattuck Labs | 25.55 | ||||
AVTE | Aerovate Therapeutics | 2.53 | ||||
ANEB | Anebulo Pharmaceuticals | 0.79 | ||||
AVIR | Atea Pharmaceuticals | 1.59 | ||||
TCRX | Tscan Therapeutics | 1.84 | ||||
IPSC | Century Therapeutics | 2.74 | ||||
ZURA | Zura Bio | 2.78 | ||||
RXRX | Recursion Pharmaceuticals | 3.02 | ||||
CGTX | Cognition Therapeutics | 3.45 | ||||
CUE | Cue Biopharma | 3.79 | ||||
DRMA | Dermata Therapeutics | 4.00 | ||||
ANNX | Annexon | 5.69 | ||||
WVE | Wave Life | 5.84 | ||||
UBX | Unity Biotechnology | 6.19 | ||||
INAB | In8bio | 6.90 | ||||
CSBR | Champions Oncology | 8.06 |
Complementary Tools for Immunoprecise Stock analysis
When running Immunoprecise Antibodies' price analysis, check to measure Immunoprecise Antibodies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunoprecise Antibodies is operating at the current time. Most of Immunoprecise Antibodies' value examination focuses on studying past and present price action to predict the probability of Immunoprecise Antibodies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunoprecise Antibodies' price. Additionally, you may evaluate how the addition of Immunoprecise Antibodies to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |